Literature DB >> 23495171

Pim1 serine/threonine kinase regulates the number and functions of murine hematopoietic stem cells.

Ningfei An1, Ying-Wei Lin, Sandeep Mahajan, Joshua N Kellner, Yong Wang, Zihai Li, Andrew S Kraft, Yubin Kang.   

Abstract

The genes and pathways that govern the functions and expansion of hematopoietic stem cells (HSC) are not completely understood. In this study, we investigated the roles of serine/threonine Pim kinases in hematopoiesis in mice. We generated PIM1 transgenic mice (Pim1-Tx) overexpressing human PIM1 driven by vav hematopoietic promoter/regulatory elements. Compared to wild-type littermates, Pim1-Tx mice showed enhanced hematopoiesis as demonstrated by increased numbers of Lin(-) Sca-1 (+) c-Kit (+) (LSK) hematopoietic stem/progenitor cells and cobblestone area forming cells, higher BrdU incorporation in long-term HSC population, and a better ability to reconstitute lethally irradiated mice. We then extended our study using Pim1(-/-), Pim2(-/-), Pim3(-/-) single knockout (KO) mice. HSCs from Pim1(-/-) KO mice showed impaired long-term hematopoietic repopulating capacity in secondary and competitive transplantations. Interestingly, these defects were not observed in HSCs from Pim2(-/-) or Pim3(-/-) KO mice. Limiting dilution competitive transplantation assay estimated that the frequency of LSKCD34(-) HSCs was reduced by approximately 28-fold in Pim1(-/-) KO mice compared to wild-type littermates. Mechanistic studies demonstrated an important role of Pim1 kinase in regulating HSC cell proliferation and survival. Finally, our polymerase chain reaction (PCR) array and confirmatory real-time PCR (RT-PCR) studies identified several genes including Lef-1, Pax5, and Gata1 in HSCs that were affected by Pim1 deletion. Our data provide the first direct evidence for the important role of Pim1 kinase in the regulation of HSCs. Our study also dissects out the relative role of individual Pim kinase in HSC functions and regulation.
Copyright © 2013 AlphaMed Press.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23495171      PMCID: PMC3664117          DOI: 10.1002/stem.1369

Source DB:  PubMed          Journal:  Stem Cells        ISSN: 1066-5099            Impact factor:   6.277


  50 in total

1.  Signal control of hematopoietic stem cell fate: Wnt, Notch, and Hedgehog as the usual suspects.

Authors:  Clint Campbell; Ruth M Risueno; Simona Salati; Borhane Guezguez; Mickie Bhatia
Journal:  Curr Opin Hematol       Date:  2008-07       Impact factor: 3.284

2.  ELDA: extreme limiting dilution analysis for comparing depleted and enriched populations in stem cell and other assays.

Authors:  Yifang Hu; Gordon K Smyth
Journal:  J Immunol Methods       Date:  2009-06-28       Impact factor: 2.303

3.  In vitro assays for cobblestone area-forming cells, LTC-IC, and CFU-C.

Authors:  Ronald P van Os; Bertien Dethmers-Ausema; Gerald de Haan
Journal:  Methods Mol Biol       Date:  2008

4.  Pim-3, a proto-oncogene with serine/threonine kinase activity, is aberrantly expressed in human pancreatic cancer and phosphorylates bad to block bad-mediated apoptosis in human pancreatic cancer cell lines.

Authors:  Ying-Yi Li; Boryana K Popivanova; Yuichiro Nagai; Hiroshi Ishikura; Chifumi Fujii; Naofumi Mukaida
Journal:  Cancer Res       Date:  2006-07-01       Impact factor: 12.701

5.  Pim-1 kinase protects hematopoietic FDC cells from genotoxin-induced death.

Authors:  T J Pircher; S Zhao; J N Geiger; B Joneja; D M Wojchowski
Journal:  Oncogene       Date:  2000-07-27       Impact factor: 9.867

6.  Evidence that the Pim1 kinase gene is a direct target of HOXA9.

Authors:  Yu-Long Hu; Emmanuelle Passegué; Stephen Fong; Corey Largman; Hugh Jeffrey Lawrence
Journal:  Blood       Date:  2007-02-27       Impact factor: 22.113

7.  Murine allogeneic in vivo stem cell homing(,).

Authors:  Gerald A Colvin; Jean-Francois Lambert; Mark S Dooner; Jan Cerny; Peter J Quesenberry
Journal:  J Cell Physiol       Date:  2007-05       Impact factor: 6.384

8.  Self-renewal of murine embryonic stem cells is supported by the serine/threonine kinases Pim-1 and Pim-3.

Authors:  Irène Aksoy; Caline Sakabedoyan; Pierre-Yves Bourillot; Anna B Malashicheva; Jimmy Mancip; Kenneth Knoblauch; Marielle Afanassieff; Pierre Savatier
Journal:  Stem Cells       Date:  2007-08-23       Impact factor: 6.277

9.  Vav promoter-tTA conditional transgene expression system for hematopoietic cells drives high level expression in developing B and T cells.

Authors:  Won-Il Kim; Stephen M Wiesner; David A Largaespada
Journal:  Exp Hematol       Date:  2007-06-07       Impact factor: 3.084

10.  Efficient retroviral transduction of human B-lymphoid and myeloid progenitors: marked inhibition of their growth by the Pax5 transgene.

Authors:  Rieko Sekine; Toshio Kitamura; Takashi Tsuji; Arinobu Tojo
Journal:  Int J Hematol       Date:  2008-05       Impact factor: 2.490

View more
  17 in total

1.  Critical role of Jak2 in the maintenance and function of adult hematopoietic stem cells.

Authors:  Hajime Akada; Saeko Akada; Robert E Hutchison; Kazuhito Sakamoto; Kay-Uwe Wagner; Golam Mohi
Journal:  Stem Cells       Date:  2014-07       Impact factor: 6.277

2.  The pan-PIM inhibitor INCB053914 displays potent synergy in combination with ruxolitinib in models of MPN.

Authors:  Lucia Mazzacurati; Robert J Collins; Garima Pandey; Que T Lambert-Showers; Narmin E Amin; Ling Zhang; Matthew C Stubbs; Pearlie K Epling-Burnette; Holly K Koblish; Gary W Reuther
Journal:  Blood Adv       Date:  2019-11-26

3.  PIM-2 protein kinase negatively regulates T cell responses in transplantation and tumor immunity.

Authors:  Anusara Daenthanasanmak; Yongxia Wu; Supinya Iamsawat; Hung D Nguyen; David Bastian; MengMeng Zhang; M Hanief Sofi; Shilpak Chatterjee; Elizabeth G Hill; Shikhar Mehrotra; Andrew S Kraft; Xue-Zhong Yu
Journal:  J Clin Invest       Date:  2018-05-21       Impact factor: 14.808

4.  PIM1 kinase as a promise of targeted therapy in prostate cancer stem cells.

Authors:  Yingqiu Xie; Samat Bayakhmetov
Journal:  Mol Clin Oncol       Date:  2015-11-09

Review 5.  Genetic Modeling of PIM Proteins in Cancer: Proviral Tagging and Cooperation with Oncogenes, Tumor Suppressor Genes, and Carcinogens.

Authors:  Enara Aguirre; Oliver Renner; Maja Narlik-Grassow; Carmen Blanco-Aparicio
Journal:  Front Oncol       Date:  2014-05-15       Impact factor: 6.244

6.  The PIM inhibitor AZD1208 synergizes with ruxolitinib to induce apoptosis of ruxolitinib sensitive and resistant JAK2-V617F-driven cells and inhibit colony formation of primary MPN cells.

Authors:  Lucia Mazzacurati; Que T Lambert; Anuradha Pradhan; Lori N Griner; Dennis Huszar; Gary W Reuther
Journal:  Oncotarget       Date:  2015-11-24

7.  The role of PIM1/PIM2 kinases in tumors of the male reproductive system.

Authors:  Manuel Pedro Jiménez-García; Antonio Lucena-Cacace; María José Robles-Frías; Maja Narlik-Grassow; Carmen Blanco-Aparicio; Amancio Carnero
Journal:  Sci Rep       Date:  2016-11-30       Impact factor: 4.379

8.  Pim1 kinase regulates c-Kit gene translation.

Authors:  Ningfei An; Bo Cen; Houjian Cai; Jin H Song; Andrew Kraft; Yubin Kang
Journal:  Exp Hematol Oncol       Date:  2016-12-30

9.  Antiplatelet properties of Pim kinase inhibition are mediated through disruption of thromboxane A2 receptor signaling.

Authors:  Amanda J Unsworth; Alexander P Bye; Tanya Sage; Renato S Gaspar; Nathan Eaton; Caleb Drew; Alexander Stainer; Neline Kriek; Peter J Volberding; James L Hutchinson; Ryan Riley; Sarah Jones; Stuart J Mundell; Weiguo Cui; Hervé Falet; Jonathan M Gibbins
Journal:  Haematologica       Date:  2021-07-01       Impact factor: 9.941

10.  Developmental stage-specific effects of Pim-1 dysregulation on murine bone marrow B cell development.

Authors:  Zhihui Xu; Kimberly A Gwin; Yulin Li; Kay L Medina
Journal:  BMC Immunol       Date:  2016-06-10       Impact factor: 3.615

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.